For decades, the familiar white bottle of baby powder was a staple in bathrooms across West Virginia and the entire country. It was a symbol of cleanliness, care, and daily routine. Families used it on infants, and many women made it a part of their personal hygiene regimen for years, trusting the brand name on the label implicitly. The idea that this household product could harbor a hidden danger—specifically asbestos—was unthinkable to the millions of consumers who relied on it.

Now, that trust has been replaced by a massive legal battle.

The Scale and Scope of the Talc Litigation

The Johnson & Johnson talc litigation has evolved into a massive legal undertaking, formally organized as a Multidistrict Litigation, or MDL. This legal structure is distinct from a class action lawsuit. In a class action, one or two people stand in for a large group. In an MDL, each case remains individual, but they are consolidated before a single federal judge for pre-trial proceedings. This allows the court to handle common issues—like discovery of documents and scientific rulings—efficiently without clogging up courthouses across the nation.

The sheer volume of cases filed in this MDL reflects the widespread use of talc-based products. Plaintiffs involved in these lawsuits typically allege that the use of Johnson’s Baby Powder and Shower to Shower products contributed to the development of ovarian cancer or mesothelioma. The central claim is not just that the powder caused cancer, but that the manufacturer knew about the potential for asbestos contamination in their talc mines and failed to warn consumers for decades.

• MDL 2738: This is the federal identifier for the consolidated proceedings, currently housed in New Jersey.
• Individual Claims: Every plaintiff has their own specific medical history, duration of product use, and diagnosis.
• Common Discovery: All plaintiffs benefit from the documents and testimony uncovered during the centralized process.

The Core Allegation: Asbestos Contamination in Talc

To comprehend why this litigation exists, you must look at the geology of talc itself. Talc is a soft mineral mined from the earth. It is often found in deposits located near asbestos, another naturally occurring mineral. Asbestos is a known carcinogen, and there is no safe level of exposure. The plaintiffs in these lawsuits argue that during the mining process, the talc was contaminated with asbestos fibers, which then made their way into the finished consumer product.

When used for feminine hygiene, the allegation is that these asbestos-tainted talc particles traveled into the body, causing chronic inflammation and eventually leading to ovarian cancer. For mesothelioma plaintiffs, the mechanism involves inhaling the powder during application, which damages the lining of the lungs. Johnson & Johnson has consistently denied these allegations, maintaining that their product is safe and asbestos-free. However, internal company documents that have surfaced during litigation suggest that concerns about asbestos testing methods and results were discussed privately by company officials long before the public was alerted.

The Bankruptcy Strategy: The “Texas Two-Step” Explained

A major point of contention in this litigation has been the legal maneuvering used by the defendant to manage its liability. This strategy, often referred to in legal circles as the “Texas Two-Step,” involves a complex corporate restructuring designed to isolate legal liabilities.

The process generally works as follows:

• Corporate Division: The company splits into two separate entities.
• Asset Allocation: One entity retains the valuable assets and business operations.
• Liability Allocation: The other entity is saddled with the legal liabilities—in this case, the tens of thousands of talc lawsuits.
• Bankruptcy Filing: The entity holding the liabilities then files for Chapter 11 bankruptcy.

The intent behind this maneuver is to halt the litigation and force a global settlement through the bankruptcy court, rather than facing juries in civil courts. This strategy effectively pauses the lawsuits, leaving plaintiffs in a state of limbo. Courts have wrestled with the legality of this move, with appellate courts previously dismissing bankruptcy filings on the grounds that the subsidiary was not in genuine financial distress. This legal tug-of-war has significantly delayed the resolution of cases for plaintiffs who are often battling serious illnesses.

Settlement Proposals and Plaintiff Responses

Throughout the litigation, Johnson & Johnson has repeatedly attempted to resolve all talc claims through large, global settlement structures, including proposals tied to bankruptcy plans and more recent non-bankruptcy settlement offers. In 2025, after multiple failed bankruptcy attempts, the company shifted back toward the tort system while still pursuing structured settlement proposals aimed at resolving current and future ovarian cancer claims.​

As of late 2025, reports indicate that at least 75% of plaintiffs have voted in favor of a proposed settlement of approximately $6.48–6.5 billion to resolve ovarian and other gynecologic cancer claims, meeting the minimum support threshold the company set for moving forward with this type of plan. Even so, serious debates remain within the plaintiffs’ bar about whether the total amount is adequate once divided among tens of thousands of claimants and reduced by fees, costs, and medical liens.​

Key factors that plaintiffs and their attorneys continue to evaluate include:

• Sufficiency of Funds: Whether the proposed aggregate amount realistically covers medical bills, lost earnings, and non-economic damages for both current and anticipated future claimants.​
• Future Claims: How the structure treats women who may be diagnosed years from now after historical talc use, including how claims will be valued and paid over time.​
• Payment Timeline and Process: The speed and mechanics of distributions, especially for seriously ill plaintiffs who may not be able to wait through prolonged appeals or additional challenges to any settlement framework.​

The Battle Over Scientific Evidence: Daubert Hearings

Before a case can ever reach a jury, the science backing the claim must pass a rigorous legal test. In federal court, this is known as a Daubert hearing. This is a critical phase where the judge acts as a gatekeeper to determine if the expert witnesses—doctors, geologists, and epidemiologists—are using sound scientific methods.

The defense often argues that the studies linking talc to ovarian cancer are inconclusive or flawed. They present their own experts who testify that no consistent causal link exists. The plaintiffs counter with histological evidence showing talc particles in ovarian tissue and epidemiological studies that show an increased risk of cancer among long-term users.

Recent rulings in the MDL have allowed key plaintiff experts to testify, acknowledging that their methodologies are reliable enough to be heard by a jury. This was a significant victory for the plaintiffs, as excluding these experts would have effectively ended the litigation. It means that the question of whether talc causes cancer is a factual dispute for a jury to decide, rather than a legal question for a judge to dismiss.

The Role of Bellwether Trials

In an MDL with this many lawsuits, it is impossible to try every single case. Instead, the court utilizes a system of “bellwether trials.” These are test cases selected to go to trial first. They are chosen because they are representative of the broader group of claims.

The outcomes of these trials serve several important functions:

• Testing Arguments: Both sides get to see how juries react to their evidence and legal theories.
• Establishing Value: Large verdicts for plaintiffs can motivate the defense to offer a higher global settlement. Conversely, defense verdicts can lower settlement expectations.
• Predicting Outcomes: They provide a roadmap for how future cases might be resolved if they proceed to trial.

We have seen varied results in state court trials that proceeded outside the MDL, with some resulting in massive verdicts for plaintiffs and others in favor of the defense. These results highlight the high stakes and unpredictability of jury trials in complex product liability cases.

The Status of the Proposed Third Bankruptcy

Following the dismissal of Johnson & Johnson’s earlier talc bankruptcy cases, the company made a third attempt in late 2024 by placing a new subsidiary, Red River Talc LLC, into Chapter 11 with a pre-packaged plan that it said was supported by a large majority of ovarian and gynecologic cancer claimants. On March 31, 2025, U.S. Bankruptcy Judge Christopher López in the Southern District of Texas rejected that third bankruptcy effort and the associated multibillion-dollar settlement proposal, finding that the filing did not meet the good‑faith and financial‑distress standards required for this type of mass‑tort bankruptcy.​

After that ruling, Johnson & Johnson publicly announced that it would return to the civil tort system to litigate talc cases rather than pursue yet another Chapter 11 filing, even as it continues to explore large‑scale settlement options outside of bankruptcy. At the same time, plaintiffs’ firms and defense counsel are preparing for a new wave of trials in federal and state courts, with multiple significant trial dates now set for late 2025 and 2026 in jurisdictions such as California, New Jersey, Pennsylvania, and Florida.​

In this context, the core controversy has shifted from whether a bankruptcy court can impose a global resolution to how much J&J will ultimately pay through a combination of negotiated settlements and jury verdicts, and how any large settlement structure will treat different categories of present and future claimants.

Medical Monitoring and Long-Term Health Concerns

For many West Virginians who used these products but have not been diagnosed with cancer, the primary concern is vigilance. Ovarian cancer is notoriously difficult to detect in its early stages. The symptoms can be vague—bloating, pelvic pain, difficulty eating, or urinary urgency—and are often dismissed as less serious ailments.

If you have a history of long-term talcum powder use, it is important to:

• Inform Your Doctor: Ensure your healthcare provider knows about your history of product use.
• Monitor Symptoms: Be aware of the warning signs of ovarian cancer and mesothelioma.
• Review Medical History: Keep records of any gynecological issues or respiratory problems.

While the litigation focuses on those who have already fallen ill, the conversation has raised awareness about product safety and the importance of ingredient transparency.

What Should Plaintiffs Do Now?

If you or a loved one has been diagnosed with ovarian cancer or mesothelioma after long-term use of talc-based baby powder, the path forward involves several specific steps. The litigation is active, and deadlines—known as statutes of limitations—apply to how long you have to file a claim after a diagnosis.

• Gather Records: Collect medical records that document the diagnosis and any tissue pathology reports.
• Establish Use: Document the history of product use. This might include personal recollections, receipts, or testimony from family members who observed the daily routine.
• Consult Counsel: Speak with a legal professional who can evaluate the specific facts of the case against the current criteria for the MDL.

The legal environment is fluid. Rulings on bankruptcy, scientific evidence, and settlement offers can change the landscape rapidly. Staying informed and prepared is the best course of action.

Advocating for Consumer Safety and Justice

The Johnson & Johnson talc litigation represents more than just a financial dispute; it is a battle over consumer trust and corporate transparency. At Powell & Majestro, P.L.L.C., we believe that West Virginians deserve to know that the products they bring into their homes are safe. We are committed to standing with those who have been harmed by corporate negligence. If you have questions about how the talc litigation affects you or a family member, or if you need guidance on your potential legal options, we are here to help. Contact us today at (304) 346-2889 or reach out through our online contact form for a free consultation. Let us help you determine the best steps to protect your rights and your future.